NYSE

Globus Medical, Inc. Class A (GMED)

360 Thanks from members

Globus Medical, Inc. (GMED) demonstrates strong financial performance with solid revenue growth and a fortress balance sheet, though near-term EPS growth deceleration and integration headwinds from the Nevro acquisition temper immediate multiple expansion.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →